| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000203706.4 |
Avagacestat |
Kidney renal clear cell carcinoma |
0.030711848 |
Resistant |
| ENSG00000203706.4 |
Avagacestat |
Sarcoma |
0.018105623 |
Resistant |
| ENSG00000203706.4 |
Avagacestat |
Head and neck squamous cell carcinoma |
0.04376424 |
Sensitive |
